News and events

Could artificial intelligence revolutionize nanobody discovery by streamlining research pipelines and unlocking novel therapeutic avenues? A recent study demonstrates that an advanced machine learning framework can predict nanobody‐protein interactions with remarkable precision, marking a transformative step for biotech innovation. The researchers leveraged a dataset of over 10,000 protein‐antibody interactions and achieved an impressive 85% prediction accuracy, surpassing traditional experimental approaches' limitations.

Recent advancements in nanotechnology have led to a breakthrough in skincare, as highlighted by a study in the Asian Journal of Pharmaceutical Sciences. The innovative hybrid extracellular vesicle (EV)/liposome system combines the natural benefits of Hydrangea macrophylla leaf extracellular vesicles (HML-EVs) with the advanced delivery capabilities of terpinene-4-ol/acrylamide monoethanolamine-loaded liposomes (TAM-liposomes). This cutting-edge system offers targeted therapeutic benefits, particularly in combating UV-induced skin inflammation.

The integration of Artificial Intelligence (AI) into nanobody development is revolutionizing biotechnology. A recent study published in Journal of Nanobiotechnology explores how AI-driven models can accelerate nanobody discovery, enhance binding affinity predictions, and streamline protein optimization.